PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-70.63%
Both yoy net incomes decline, with MCHP at -38.88%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-1.29%
Both reduce yoy D&A, with MCHP at -2.97%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-12.20%
Negative yoy deferred tax while MCHP stands at 1177.32%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-23.03%
Negative yoy working capital usage while MCHP is 57.73%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-75.28%
Negative yoy inventory while MCHP is 30.91%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-10.79%
Negative yoy usage while MCHP is 21.38%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
102.19%
Well above MCHP's 109.14%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-34.43%
Negative yoy CFO while MCHP is 10.03%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
26.20%
Some CapEx rise while MCHP is negative at -70.18%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Some acquisitions while MCHP is negative at -8.33%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
56.46%
Purchases well above MCHP's 5.62%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
30.23%
Below 50% of MCHP's 77.45%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-100.00%
We reduce yoy other investing while MCHP is 143.42%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-34.55%
We reduce yoy invests while MCHP stands at 53.36%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-35.04%
Negative yoy issuance while MCHP is 34.99%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-63.45%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.